Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Fibrosis × Tenofovir × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hepatitis B, Chronic 2 Carcinoma, Hepatocellular 2 Recurrence 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Fibrosis 1 Burkitt Lymphoma 1

Interventions

sofosbuvir-velpatasvir drug combination 1 apixaban 1 Tenofovir 1 Gemcitabine 1 Enoxaparin 1 Clinical Trials as Topic 1 BCG Vaccine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02224456 2022-02-14

Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis

GlaxoSmithKline

Phase 4 Completed

197 enrolled 27 charts

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Hepatitis B, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡